India bans export of Trump’s ‘game changer’ COVID-19 drug hydroxychloroquine


 India bans all exports of hydroxychloroquine, a malaria drug that President Donald Trump has repeatedly touted as a “game changer” in the fight against Covid-19.

India has put a total ban on exports of hydroxychloroquine, a malaria drug that several countries, including the United States sought from India to fight Covid.19.

A Hindustan Times report said that India’s Directorate General of Foreign Trade has imposed the ban on April 4, the day US President Donald Trump made a personal request with Prime Minister Narendra Modi for the drug.

It is not clear whether the government will allow any exceptions. Chances are dim since several other countries, including Brazil, has sought the drug which they consider as a game changer in the fight against Kovid. The cabinet meeting later in the day is expected to take a decision on this.

The trade regulator had last month restricted overseas shipments of the drug, allowing only limited exceptions such as on humanitarian grounds

Under the fresh directive, exports of the drug and its formulations have been prohibited “without any exceptions" and with immediate effect. The new ban reflects India’s rising concern over the rapid spread of the novel coronavirus, with incidents of community spread emerging from different parts of the country of 1.3 billion people.

India has recorded 4,067 positive cases and has lost 109 lives, according to the union health ministry. The pandemic has spread across 183 countries. Globally, there have been over 12.7 lakh confirmed cases of COVID-19. At least 69,400 people have died so far.

Cases continue to rise in the United States, Spain, Italy, Germany and France, among others. The outbreak is having a major impact on global economy and the stock market.

Image Credit:

All Comments